ENTRADA THERAPEUTICS INC
TRDANASDAQ🏆 #3023 by market capEarnings Nov 5US Equity
$7.13▲ $0.09 (+1.28%)
Live1h▲ 2.3%
24h▲ 1.3%
7d▲ 0.6%
14d▲ 8.9%
30d▲ 8.2%
1y▲ 38.3%
🏦Market Cap
$277M
Small Cap
📈Revenue Growth (YoY)
-94.1%
Declining
📊Gross Margin
—
💵FCF Margin
1674.4%
Strong
⚖️P/S Ratio
57.7x
Expensive
Otter Score
51
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
-1.01
Expected
-0.97
miss
−3.70%
YoY +2.90%
Revenue
Actual
$898.00K
Expected
$2.32M
miss
−61.40%
YoY −53.90%
Consensus estimates
Recent quarters
Q3 2026
-1.01
miss
Q2 2026
-0.95
beat
Q1 2026
-0.94
beat
Q4 2025
-1.06
miss